Cargando…
Correction: Systemic pro-inflammatory response identifies patients with cancer with adverse outcomes from SARS-CoV-2 infection: the OnCovid Inflammatory Score
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8211064/ https://www.ncbi.nlm.nih.gov/pubmed/34135105 http://dx.doi.org/10.1136/jitc-2020-002277corr1 |
Ejemplares similares
-
Systemic pro-inflammatory response identifies patients with cancer with adverse outcomes from SARS-CoV-2 infection: the OnCovid Inflammatory Score
por: Dettorre, Gino M, et al.
Publicado: (2021) -
319O The systemic pro-inflammatory response identifies cancer patients with adverse outcomes from SARS-CoV-2 infection
por: Dettorre, G., et al.
Publicado: (2020) -
Correction to: Short-term outcomes in children recovered from multisystem inflammatory syndrome associated with SARS-CoV-2 infection
por: Patnaik, Sibabratta, et al.
Publicado: (2021) -
Correction to: Circulating calprotectin as a supporting inflammatory marker in discriminating SARS-CoV-2 infection: an observational study
por: Cherubini, Fabio, et al.
Publicado: (2021) -
Correction to: Elevated plasma IL-6 and CRP levels are associated with adverse clinical outcomes and death in critically ill SARS-CoV-2 patients: infammatory response of SARS-CoV-2 patients
por: Lavillegrand, Jean-Rémi, et al.
Publicado: (2021)